302 related articles for article (PubMed ID: 15001201)
1. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat.
Zhang Y; Croft KD; Mori TA; Schyvens CG; McKenzie KU; Whitworth JA
Am J Hypertens; 2004 Mar; 17(3):260-5. PubMed ID: 15001201
[TBL] [Abstract][Full Text] [Related]
2. Aspirin prevents and partially reverses adrenocorticotropic hormone-induced hypertension in the rat.
Zhang Y; Miao Y; Whitworth JA
Am J Hypertens; 2007 Nov; 20(11):1222-8. PubMed ID: 17954371
[TBL] [Abstract][Full Text] [Related]
3. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat.
Hu L; Zhang Y; Lim PS; Miao Y; Tan C; McKenzie KU; Schyvens CG; Whitworth JA
Am J Hypertens; 2006 Apr; 19(4):413-8. PubMed ID: 16580579
[TBL] [Abstract][Full Text] [Related]
4. Folic acid prevents and partially reverses glucocorticoid-induced hypertension in the rat.
Miao Y; Zhang Y; Lim PS; Kanjanapan Y; Mori TA; Croft KD; Earl J; Lee SY; McKenzie KU; Hu L; Whitworth JA
Am J Hypertens; 2007 Mar; 20(3):304-10. PubMed ID: 17324744
[TBL] [Abstract][Full Text] [Related]
5. N-Acetylcysteine prevents but does not reverse dexamethasone-induced hypertension.
Krug S; Zhang Y; Mori TA; Croft KD; Vickers JJ; Langton LK; Whitworth JA
Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):979-81. PubMed ID: 18430051
[TBL] [Abstract][Full Text] [Related]
6. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
Zhang Y; Chan MM; Andrews MC; Mori TA; Croft KD; McKenzie KU; Schyvens CG; Whitworth JA
Am J Hypertens; 2005 Jul; 18(7):910-6. PubMed ID: 16053986
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin prevented and reversed dexamethasone-induced hypertension in the rat.
Mondo CK; Yang WS; Su JZ; Huang TG
Clin Exp Hypertens; 2006 Jul; 28(5):499-509. PubMed ID: 16820346
[TBL] [Abstract][Full Text] [Related]
8. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
Iglarz M; Touyz RM; Viel EC; Amiri F; Schiffrin EL
Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
[TBL] [Abstract][Full Text] [Related]
9. The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat.
Zhang Y; Jang R; Mori TA; Croft KD; Schyvens CG; McKenzie KU; Whitworth JA
J Hypertens; 2003 Aug; 21(8):1513-8. PubMed ID: 12872045
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
11. Anti-oxidant effects of atorvastatin in dexamethasone-induced hypertension in the rat.
Mondo CK; Yang WS; Zhang N; Huang TG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1029-34. PubMed ID: 17042910
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamics of dexamethasone-induced hypertension in the rat.
Ong SL; Zhang Y; Sutton M; Whitworth JA
Hypertens Res; 2009 Oct; 32(10):889-94. PubMed ID: 19644504
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin prevented and partially reversed adrenocorticotropic hormone-induced hypertension in the rat.
Mondo CK; Yang WS; Su JZ; Huang TG
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):369-73. PubMed ID: 16620303
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid metabolism in glucocorticoid-induced hypertension.
Zhang Y; Hu L; Mori TA; Barden A; Croft KD; Whitworth JA
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):557-62. PubMed ID: 18067589
[TBL] [Abstract][Full Text] [Related]
15. Adrenocorticotropic hormone, blood pressure, and serum erythropoietin concentrations in the rat.
Zhang Y; Andrews MC; Schyvens CG; McKenzie KU; Whitworth JA
Am J Hypertens; 2004 May; 17(5 Pt 1):457-61. PubMed ID: 15110907
[TBL] [Abstract][Full Text] [Related]
16. Effects of sepiapterin supplementation and NOS inhibition on glucocorticoid-induced hypertension.
Thida M; Earl J; Zhao Y; Wang H; Tse CS; Vickers JJ; Sutton M; Ong SL; Mori TA; Croft KD; Whitworth JA; Zhang Y
Am J Hypertens; 2010 May; 23(5):569-74. PubMed ID: 20186125
[TBL] [Abstract][Full Text] [Related]
17. Role of xanthine oxidase in dexamethasone-induced hypertension in rats.
Ong SL; Vickers JJ; Zhang Y; McKenzie KU; Walsh CE; Whitworth JA
Clin Exp Pharmacol Physiol; 2007; 34(5-6):517-9. PubMed ID: 17439425
[TBL] [Abstract][Full Text] [Related]
18. Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.
Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Malý J; Kramer HJ; Dvorák P; Cervenka L
Vascul Pharmacol; 2009; 51(2-3):175-81. PubMed ID: 19539780
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
[TBL] [Abstract][Full Text] [Related]
20. Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats.
Sullivan JC; Pollock JS; Pollock DM
Exp Biol Med (Maywood); 2006 Jun; 231(6):818-23. PubMed ID: 16741005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
